APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Papillomavirus Protein E7

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Papillomavirus Protein E7 Market Analysis and Forecast 2026-2032

19 December 2025208 pages

Choose your research edition.

Industry ResearchHuman Papillomavirus Protein E7 Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Papillomavirus Protein E7 Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Human Papillomavirus Protein E7 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Papillomavirus Protein E7 Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Papillomavirus Protein E7 Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Human Papillomavirus Protein E7 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Papillomavirus Protein E7 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Papillomavirus Protein E7 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Papillomavirus Protein E7 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Papillomavirus Protein E7 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Papillomavirus Protein E7 include VLPbio, Transgene SA, Touchlight Genetics Ltd, Selecta Biosciences Inc, MedImmune LLC, Inovio Pharmaceuticals Inc, Immunovaccine Inc, iBio Inc and Hookipa Biotech AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Papillomavirus Protein E7, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Papillomavirus Protein E7, also provides the sales of main regions and countries. Of the upcoming market potential for Human Papillomavirus Protein E7, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Papillomavirus Protein E7 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Papillomavirus Protein E7 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Papillomavirus Protein E7 sales, projected growth trends, production technology, application and end-user industry.

Human Papillomavirus Protein E7 Segment by Company

VLPbio

Transgene SA

Touchlight Genetics Ltd

Selecta Biosciences Inc

MedImmune LLC

Inovio Pharmaceuticals Inc

Immunovaccine Inc

iBio Inc

Hookipa Biotech AG

Genexine Inc

Formune SL

Etubics Corp

Cancer Research Technology Ltd

BioNTech AG

Bioleaders Corp

Advaxis Inc

Abion Inc

Human Papillomavirus Protein E7 Segment by Type

CUE-201

CerviVax

CUE-101

BLSILSB-710c

Others

Human Papillomavirus Protein E7 Segment by Application

Rectal Cancer

Penile Cancer

Anal Cancer

Lung Cancer

Others

Human Papillomavirus Protein E7 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Papillomavirus Protein E7 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Papillomavirus Protein E7 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Papillomavirus Protein E7.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Papillomavirus Protein E7 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Papillomavirus Protein E7 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Papillomavirus Protein E7 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Papillomavirus Protein E7 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CUE-201 Major Manufacturers Table 3. CerviVax Major Manufacturers Table 4. CUE-101 Major Manufacturers Table 5. BLSILSB-710c Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Human Papillomavirus Protein E7 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Rectal Cancer Major Manufacturers Table 9. Penile Cancer Major Manufacturers Table 10. Anal Cancer Major Manufacturers Table 11. Lung Cancer Major Manufacturers Table 12. Others Major Manufacturers Table 13. Human Papillomavirus Protein E7 Industry Trends Table 14. Human Papillomavirus Protein E7 Industry Drivers Table 15. Human Papillomavirus Protein E7 Industry Opportunities and Challenges Table 16. Human Papillomavirus Protein E7 Industry Restraints Table 17. Global Human Papillomavirus Protein E7 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Human Papillomavirus Protein E7 Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Human Papillomavirus Protein E7 Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Human Papillomavirus Protein E7 Revenue Market Share by Region (2021-2026) Table 21. Global Human Papillomavirus Protein E7 Revenue Market Share by Region (2027-2032) Table 22. Global Human Papillomavirus Protein E7 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Human Papillomavirus Protein E7 Sales by Region (2021-2026) & (K Units) Table 24. Global Human Papillomavirus Protein E7 Sales by Region (2027-2032) & (K Units) Table 25. Global Human Papillomavirus Protein E7 Sales Market Share by Region (2021-2026) Table 26. Global Human Papillomavirus Protein E7 Sales Market Share by Region (2027-2032) Table 27. Global Human Papillomavirus Protein E7 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Human Papillomavirus Protein E7 Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Human Papillomavirus Protein E7 Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Human Papillomavirus Protein E7 Sales Market Share by Manufacturers (2021-2026) Table 31. Global Human Papillomavirus Protein E7 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Human Papillomavirus Protein E7 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Human Papillomavirus Protein E7 Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Human Papillomavirus Protein E7 Manufacturers, Product Type & Application Table 35. Global Human Papillomavirus Protein E7 Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Human Papillomavirus Protein E7 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Human Papillomavirus Protein E7 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Human Papillomavirus Protein E7 Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Human Papillomavirus Protein E7 Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2021-2026) Table 42. Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2027-2032) Table 43. Global Human Papillomavirus Protein E7 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Human Papillomavirus Protein E7 Sales by Type (2021-2026) & (K Units) Table 45. Global Human Papillomavirus Protein E7 Sales by Type (2027-2032) & (K Units) Table 46. Global Human Papillomavirus Protein E7 Sales Market Share by Type (2021-2026) Table 47. Global Human Papillomavirus Protein E7 Sales Market Share by Type (2027-2032) Table 48. Global Human Papillomavirus Protein E7 Price by Type (2021-2026) & (US$/Unit) Table 49. Global Human Papillomavirus Protein E7 Price by Type (2027-2032) & (US$/Unit) Table 50. Global Human Papillomavirus Protein E7 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Human Papillomavirus Protein E7 Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Human Papillomavirus Protein E7 Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2021-2026) Table 54. Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2027-2032) Table 55. Global Human Papillomavirus Protein E7 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Human Papillomavirus Protein E7 Sales by Application (2021-2026) & (K Units) Table 57. Global Human Papillomavirus Protein E7 Sales by Application (2027-2032) & (K Units) Table 58. Global Human Papillomavirus Protein E7 Sales Market Share by Application (2021-2026) Table 59. Global Human Papillomavirus Protein E7 Sales Market Share by Application (2027-2032) Table 60. Global Human Papillomavirus Protein E7 Price by Application (2021-2026) & (US$/Unit) Table 61. Global Human Papillomavirus Protein E7 Price by Application (2027-2032) & (US$/Unit) Table 62. VLPbio Company Information Table 63. VLPbio Business Overview Table 64. VLPbio Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. VLPbio Human Papillomavirus Protein E7 Product Portfolio Table 66. VLPbio Recent Development Table 67. Transgene SA Company Information Table 68. Transgene SA Business Overview Table 69. Transgene SA Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Transgene SA Human Papillomavirus Protein E7 Product Portfolio Table 71. Transgene SA Recent Development Table 72. Touchlight Genetics Ltd Company Information Table 73. Touchlight Genetics Ltd Business Overview Table 74. Touchlight Genetics Ltd Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Touchlight Genetics Ltd Human Papillomavirus Protein E7 Product Portfolio Table 76. Touchlight Genetics Ltd Recent Development Table 77. Selecta Biosciences Inc Company Information Table 78. Selecta Biosciences Inc Business Overview Table 79. Selecta Biosciences Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Selecta Biosciences Inc Human Papillomavirus Protein E7 Product Portfolio Table 81. Selecta Biosciences Inc Recent Development Table 82. MedImmune LLC Company Information Table 83. MedImmune LLC Business Overview Table 84. MedImmune LLC Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. MedImmune LLC Human Papillomavirus Protein E7 Product Portfolio Table 86. MedImmune LLC Recent Development Table 87. Inovio Pharmaceuticals Inc Company Information Table 88. Inovio Pharmaceuticals Inc Business Overview Table 89. Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Product Portfolio Table 91. Inovio Pharmaceuticals Inc Recent Development Table 92. Immunovaccine Inc Company Information Table 93. Immunovaccine Inc Business Overview Table 94. Immunovaccine Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Immunovaccine Inc Human Papillomavirus Protein E7 Product Portfolio Table 96. Immunovaccine Inc Recent Development Table 97. iBio Inc Company Information Table 98. iBio Inc Business Overview Table 99. iBio Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. iBio Inc Human Papillomavirus Protein E7 Product Portfolio Table 101. iBio Inc Recent Development Table 102. Hookipa Biotech AG Company Information Table 103. Hookipa Biotech AG Business Overview Table 104. Hookipa Biotech AG Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Hookipa Biotech AG Human Papillomavirus Protein E7 Product Portfolio Table 106. Hookipa Biotech AG Recent Development Table 107. Genexine Inc Company Information Table 108. Genexine Inc Business Overview Table 109. Genexine Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Genexine Inc Human Papillomavirus Protein E7 Product Portfolio Table 111. Genexine Inc Recent Development Table 112. Formune SL Company Information Table 113. Formune SL Business Overview Table 114. Formune SL Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Formune SL Human Papillomavirus Protein E7 Product Portfolio Table 116. Formune SL Recent Development Table 117. Etubics Corp Company Information Table 118. Etubics Corp Business Overview Table 119. Etubics Corp Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Etubics Corp Human Papillomavirus Protein E7 Product Portfolio Table 121. Etubics Corp Recent Development Table 122. Cancer Research Technology Ltd Company Information Table 123. Cancer Research Technology Ltd Business Overview Table 124. Cancer Research Technology Ltd Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Cancer Research Technology Ltd Human Papillomavirus Protein E7 Product Portfolio Table 126. Cancer Research Technology Ltd Recent Development Table 127. BioNTech AG Company Information Table 128. BioNTech AG Business Overview Table 129. BioNTech AG Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. BioNTech AG Human Papillomavirus Protein E7 Product Portfolio Table 131. BioNTech AG Recent Development Table 132. Bioleaders Corp Company Information Table 133. Bioleaders Corp Business Overview Table 134. Bioleaders Corp Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Bioleaders Corp Human Papillomavirus Protein E7 Product Portfolio Table 136. Bioleaders Corp Recent Development Table 137. Advaxis Inc Company Information Table 138. Advaxis Inc Business Overview Table 139. Advaxis Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Advaxis Inc Human Papillomavirus Protein E7 Product Portfolio Table 141. Advaxis Inc Recent Development Table 142. Abion Inc Company Information Table 143. Abion Inc Business Overview Table 144. Abion Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Abion Inc Human Papillomavirus Protein E7 Product Portfolio Table 146. Abion Inc Recent Development Table 147. North America Human Papillomavirus Protein E7 Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Human Papillomavirus Protein E7 Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Human Papillomavirus Protein E7 Sales by Type (2021-2026) & (K Units) Table 150. North America Human Papillomavirus Protein E7 Sales by Type (2027-2032) & (K Units) Table 151. North America Human Papillomavirus Protein E7 Sales Price by Type (2021-2026) & (US$/Unit) Table 152. North America Human Papillomavirus Protein E7 Sales Price by Type (2027-2032) & (US$/Unit) Table 153. North America Human Papillomavirus Protein E7 Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Human Papillomavirus Protein E7 Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Human Papillomavirus Protein E7 Sales by Application (2021-2026) & (K Units) Table 156. North America Human Papillomavirus Protein E7 Sales by Application (2027-2032) & (K Units) Table 157. North America Human Papillomavirus Protein E7 Sales Price by Application (2021-2026) & (US$/Unit) Table 158. North America Human Papillomavirus Protein E7 Sales Price by Application (2027-2032) & (US$/Unit) Table 159. North America Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. North America Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. North America Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. North America Human Papillomavirus Protein E7 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. North America Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 164. North America Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 165. North America Human Papillomavirus Protein E7 Sales Price by Country (2021-2026) & (US$/Unit) Table 166. North America Human Papillomavirus Protein E7 Sales Price by Country (2027-2032) & (US$/Unit) Table 167. United States Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 168. Canada Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 169. Europe Human Papillomavirus Protein E7 Revenue by Type (2021-2026) & (US$ Million) Table 170. Europe Human Papillomavirus Protein E7 Revenue by Type (2027-2032) & (US$ Million) Table 171. Europe Human Papillomavirus Protein E7 Sales by Type (2021-2026) & (K Units) Table 172. Europe Human Papillomavirus Protein E7 Sales by Type (2027-2032) & (K Units) Table 173. Europe Human Papillomavirus Protein E7 Sales Price by Type (2021-2026) & (US$/Unit) Table 174. Europe Human Papillomavirus Protein E7 Sales Price by Type (2027-2032) & (US$/Unit) Table 175. Europe Human Papillomavirus Protein E7 Revenue by Application (2021-2026) & (US$ Million) Table 176. Europe Human Papillomavirus Protein E7 Revenue by Application (2027-2032) & (US$ Million) Table 177. Europe Human Papillomavirus Protein E7 Sales by Application (2021-2026) & (K Units) Table 178. Europe Human Papillomavirus Protein E7 Sales by Application (2027-2032) & (K Units) Table 179. Europe Human Papillomavirus Protein E7 Sales Price by Application (2021-2026) & (US$/Unit) Table 180. Europe Human Papillomavirus Protein E7 Sales Price by Application (2027-2032) & (US$/Unit) Table 181. Europe Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Europe Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. Europe Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. Europe Human Papillomavirus Protein E7 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. Europe Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 186. Europe Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 187. Europe Human Papillomavirus Protein E7 Sales Price by Country (2021-2026) & (US$/Unit) Table 188. Europe Human Papillomavirus Protein E7 Sales Price by Country (2027-2032) & (US$/Unit) Table 189. Germany Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 190. France Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 191. U.K. Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 192. Italy Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 193. Netherlands Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 194. China Human Papillomavirus Protein E7 Revenue by Type (2021-2026) & (US$ Million) Table 195. China Human Papillomavirus Protein E7 Revenue by Type (2027-2032) & (US$ Million) Table 196. China Human Papillomavirus Protein E7 Sales by Type (2021-2026) & (K Units) Table 197. China Human Papillomavirus Protein E7 Sales by Type (2027-2032) & (K Units) Table 198. China Human Papillomavirus Protein E7 Sales Price by Type (2021-2026) & (US$/Unit) Table 199. China Human Papillomavirus Protein E7 Sales Price by Type (2027-2032) & (US$/Unit) Table 200. China Human Papillomavirus Protein E7 Revenue by Application (2021-2026) & (US$ Million) Table 201. China Human Papillomavirus Protein E7 Revenue by Application (2027-2032) & (US$ Million) Table 202. China Human Papillomavirus Protein E7 Sales by Application (2021-2026) & (K Units) Table 203. China Human Papillomavirus Protein E7 Sales by Application (2027-2032) & (K Units) Table 204. China Human Papillomavirus Protein E7 Sales Price by Application (2021-2026) & (US$/Unit) Table 205. China Human Papillomavirus Protein E7 Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Asia Human Papillomavirus Protein E7 Revenue by Type (2021-2026) & (US$ Million) Table 207. Asia Human Papillomavirus Protein E7 Revenue by Type (2027-2032) & (US$ Million) Table 208. Asia Human Papillomavirus Protein E7 Sales by Type (2021-2026) & (K Units) Table 209. Asia Human Papillomavirus Protein E7 Sales by Type (2027-2032) & (K Units) Table 210. Asia Human Papillomavirus Protein E7 Sales Price by Type (2021-2026) & (US$/Unit) Table 211. Asia Human Papillomavirus Protein E7 Sales Price by Type (2027-2032) & (US$/Unit) Table 212. Asia Human Papillomavirus Protein E7 Revenue by Application (2021-2026) & (US$ Million) Table 213. Asia Human Papillomavirus Protein E7 Revenue by Application (2027-2032) & (US$ Million) Table 214. Asia Human Papillomavirus Protein E7 Sales by Application (2021-2026) & (K Units) Table 215. Asia Human Papillomavirus Protein E7 Sales by Application (2027-2032) & (K Units) Table 216. Asia Human Papillomavirus Protein E7 Sales Price by Application (2021-2026) & (US$/Unit) Table 217. Asia Human Papillomavirus Protein E7 Sales Price by Application (2027-2032) & (US$/Unit) Table 218. Asia Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. Asia Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. Asia Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. Asia Human Papillomavirus Protein E7 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 222. Asia Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 223. Asia Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 224. Asia Human Papillomavirus Protein E7 Sales Price by Country (2021-2026) & (US$/Unit) Table 225. Asia Human Papillomavirus Protein E7 Sales Price by Country (2027-2032) & (US$/Unit) Table 226. Japan Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 227. South Korea Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 228. India Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 229. Australia Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 230. China Taiwan Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 231. Southeast Asia Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 232. SAMEA Human Papillomavirus Protein E7 Revenue by Type (2021-2026) & (US$ Million) Table 233. SAMEA Human Papillomavirus Protein E7 Revenue by Type (2027-2032) & (US$ Million) Table 234. SAMEA Human Papillomavirus Protein E7 Sales by Type (2021-2026) & (K Units) Table 235. SAMEA Human Papillomavirus Protein E7 Sales by Type (2027-2032) & (K Units) Table 236. SAMEA Human Papillomavirus Protein E7 Sales Price by Type (2021-2026) & (US$/Unit) Table 237. SAMEA Human Papillomavirus Protein E7 Sales Price by Type (2027-2032) & (US$/Unit) Table 238. SAMEA Human Papillomavirus Protein E7 Revenue by Application (2021-2026) & (US$ Million) Table 239. SAMEA Human Papillomavirus Protein E7 Revenue by Application (2027-2032) & (US$ Million) Table 240. SAMEA Human Papillomavirus Protein E7 Sales by Application (2021-2026) & (K Units) Table 241. SAMEA Human Papillomavirus Protein E7 Sales by Application (2027-2032) & (K Units) Table 242. SAMEA Human Papillomavirus Protein E7 Sales Price by Application (2021-2026) & (US$/Unit) Table 243. SAMEA Human Papillomavirus Protein E7 Sales Price by Application (2027-2032) & (US$/Unit) Table 244. SAMEA Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. SAMEA Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. SAMEA Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. SAMEA Human Papillomavirus Protein E7 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 248. SAMEA Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 249. SAMEA Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 250. SAMEA Human Papillomavirus Protein E7 Sales Price by Country (2021-2026) & (US$/Unit) Table 251. SAMEA Human Papillomavirus Protein E7 Sales Price by Country (2027-2032) & (US$/Unit) Table 252. Brazil Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 253. Argentina Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 254. Chile Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 255. Colombia Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 256. Peru Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 257. Saudi Arabia Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 258. Israel Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 259. UAE Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 260. Turkey Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 261. Iran Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 262. Egypt Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Table 263. Key Raw Materials Table 264. Raw Materials Key Suppliers Table 265. Human Papillomavirus Protein E7 Distributors List Table 266. Human Papillomavirus Protein E7 Customers List Table 267. Research Programs/Design for This Report Table 268. Authors List of This Report Table 269. Secondary Sources Table 270. Primary Sources List of Figures Figure 1. Human Papillomavirus Protein E7 Image Figure 2. Global Human Papillomavirus Protein E7 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Papillomavirus Protein E7 Market Size Share 2021 VS 2025 VS 2032 Figure 4. CUE-201 Image Figure 5. CerviVax Image Figure 6. CUE-101 Image Figure 7. BLSILSB-710c Image Figure 8. Others Image Figure 9. Global Human Papillomavirus Protein E7 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Human Papillomavirus Protein E7 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Rectal Cancer Image Figure 12. Penile Cancer Image Figure 13. Anal Cancer Image Figure 14. Lung Cancer Image Figure 15. Others Image Figure 16. Global Human Papillomavirus Protein E7 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Human Papillomavirus Protein E7 Revenue (2021-2032) & (US$ Million) Figure 18. Global Human Papillomavirus Protein E7 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Human Papillomavirus Protein E7 Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Human Papillomavirus Protein E7 Revenue Market Share by Region (2021-2032) Figure 21. Global Human Papillomavirus Protein E7 Sales (2021-2032) & (K Units) Figure 22. Global Human Papillomavirus Protein E7 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Human Papillomavirus Protein E7 Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Human Papillomavirus Protein E7 Sales YoY (2021-2032) & (K Units) Figure 25. Europe Human Papillomavirus Protein E7 Sales YoY (2021-2032) & (K Units) Figure 26. China Human Papillomavirus Protein E7 Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Human Papillomavirus Protein E7 Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Human Papillomavirus Protein E7 Sales YoY (2021-2032) & (K Units) Figure 29. Global Human Papillomavirus Protein E7 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Human Papillomavirus Protein E7 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Human Papillomavirus Protein E7 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Human Papillomavirus Protein E7 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2021-2032) Figure 35. Global Human Papillomavirus Protein E7 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Human Papillomavirus Protein E7 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Human Papillomavirus Protein E7 Sales Market Share by Type (2021-2032) Figure 38. Global Human Papillomavirus Protein E7 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Human Papillomavirus Protein E7 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2021-2032) Figure 41. Global Human Papillomavirus Protein E7 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Human Papillomavirus Protein E7 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Human Papillomavirus Protein E7 Sales Market Share by Application (2021-2032) Figure 44. North America Human Papillomavirus Protein E7 Revenue Share by Type (2021-2032) Figure 45. North America Human Papillomavirus Protein E7 Sales Share by Type (2021-2032) Figure 46. North America Human Papillomavirus Protein E7 Revenue Share by Application (2021-2032) Figure 47. North America Human Papillomavirus Protein E7 Sales Share by Application (2021-2032) Figure 48. North America Human Papillomavirus Protein E7 Revenue Share by Country (2021-2032) Figure 49. North America Human Papillomavirus Protein E7 Sales Share by Country (2021-2032) Figure 50. Europe Human Papillomavirus Protein E7 Revenue Share by Type (2021-2032) Figure 51. Europe Human Papillomavirus Protein E7 Sales Share by Type (2021-2032) Figure 52. Europe Human Papillomavirus Protein E7 Revenue Share by Application (2021-2032) Figure 53. Europe Human Papillomavirus Protein E7 Sales Share by Application (2021-2032) Figure 54. Europe Human Papillomavirus Protein E7 Revenue Share by Country (2021-2032) Figure 55. Europe Human Papillomavirus Protein E7 Sales Share by Country (2021-2032) Figure 56. China Human Papillomavirus Protein E7 Revenue Share by Type (2021-2032) Figure 57. China Human Papillomavirus Protein E7 Sales Share by Type (2021-2032) Figure 58. China Human Papillomavirus Protein E7 Revenue Share by Application (2021-2032) Figure 59. China Human Papillomavirus Protein E7 Sales Share by Application (2021-2032) Figure 60. Asia Human Papillomavirus Protein E7 Revenue Share by Type (2021-2032) Figure 61. Asia Human Papillomavirus Protein E7 Sales Share by Type (2021-2032) Figure 62. Asia Human Papillomavirus Protein E7 Revenue Share by Application (2021-2032) Figure 63. Asia Human Papillomavirus Protein E7 Sales Share by Application (2021-2032) Figure 64. Asia Human Papillomavirus Protein E7 Revenue Share by Country (2021-2032) Figure 65. Asia Human Papillomavirus Protein E7 Sales Share by Country (2021-2032) Figure 66. SAMEA Human Papillomavirus Protein E7 Revenue Share by Type (2021-2032) Figure 67. SAMEA Human Papillomavirus Protein E7 Sales Share by Type (2021-2032) Figure 68. SAMEA Human Papillomavirus Protein E7 Revenue Share by Application (2021-2032) Figure 69. SAMEA Human Papillomavirus Protein E7 Sales Share by Application (2021-2032) Figure 70. SAMEA Human Papillomavirus Protein E7 Revenue Share by Country (2021-2032) Figure 71. SAMEA Human Papillomavirus Protein E7 Sales Share by Country (2021-2032) Figure 72. Human Papillomavirus Protein E7 Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Human Papillomavirus Protein E7 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • CUE-201
  • CerviVax
  • CUE-101
  • BLSILSB-710c
  • Others
Applications
  • Rectal Cancer
  • Penile Cancer
  • Anal Cancer
  • Lung Cancer
  • Others
Companies covered
  • VLPbio
  • Transgene SA
  • Touchlight Genetics Ltd
  • Selecta Biosciences Inc
  • MedImmune LLC
  • Inovio Pharmaceuticals Inc
  • Immunovaccine Inc
  • iBio Inc
  • Hookipa Biotech AG
  • Genexine Inc
  • Formune SL
  • Etubics Corp
  • Cancer Research Technology Ltd
  • BioNTech AG
  • Bioleaders Corp
  • Advaxis Inc
  • Abion Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Papillomavirus Protein E7 Market by Type
  3. 1.2.1 Global Human Papillomavirus Protein E7 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CUE-201
  5. 1.2.3 CerviVax
  6. 1.2.4 CUE-101
  7. 1.2.5 BLSILSB-710c
  8. 1.2.6 Others
  9. 1.3 Human Papillomavirus Protein E7 Market by Application
  10. 1.3.1 Global Human Papillomavirus Protein E7 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Rectal Cancer
  12. 1.3.3 Penile Cancer
  13. 1.3.4 Anal Cancer
  14. 1.3.5 Lung Cancer
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Human Papillomavirus Protein E7 Market Dynamics
  1. 2.1 Human Papillomavirus Protein E7 Industry Trends
  2. 2.2 Human Papillomavirus Protein E7 Industry Drivers
  3. 2.3 Human Papillomavirus Protein E7 Industry Opportunities and Challenges
  4. 2.4 Human Papillomavirus Protein E7 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Papillomavirus Protein E7 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Papillomavirus Protein E7 Revenue by Region
  3. 3.2.1 Global Human Papillomavirus Protein E7 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Papillomavirus Protein E7 Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Papillomavirus Protein E7 Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Papillomavirus Protein E7 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Papillomavirus Protein E7 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Papillomavirus Protein E7 Sales by Region
  9. 3.4.1 Global Human Papillomavirus Protein E7 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Papillomavirus Protein E7 Sales by Region (2021-2026)
  11. 3.4.3 Global Human Papillomavirus Protein E7 Sales by Region (2027-2032)
  12. 3.4.4 Global Human Papillomavirus Protein E7 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Papillomavirus Protein E7 Revenue by Manufacturers
  2. 4.1.1 Global Human Papillomavirus Protein E7 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Papillomavirus Protein E7 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Papillomavirus Protein E7 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Papillomavirus Protein E7 Sales by Manufacturers
  6. 4.2.1 Global Human Papillomavirus Protein E7 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Papillomavirus Protein E7 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Papillomavirus Protein E7 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Papillomavirus Protein E7 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Papillomavirus Protein E7 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Papillomavirus Protein E7 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Papillomavirus Protein E7 Manufacturers, Product Type & Application
  13. 4.7 Global Human Papillomavirus Protein E7 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Papillomavirus Protein E7 Market CR5 and HHI
  16. 4.8.2 2025 Human Papillomavirus Protein E7 Tier 1, Tier 2, and Tier 3
5 Human Papillomavirus Protein E7 Market by Type
  1. 5.1 Global Human Papillomavirus Protein E7 Revenue by Type
  2. 5.1.1 Global Human Papillomavirus Protein E7 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Papillomavirus Protein E7 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Papillomavirus Protein E7 Sales by Type
  6. 5.2.1 Global Human Papillomavirus Protein E7 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Papillomavirus Protein E7 Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Human Papillomavirus Protein E7 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Papillomavirus Protein E7 Price by Type
6 Human Papillomavirus Protein E7 Market by Application
  1. 6.1 Global Human Papillomavirus Protein E7 Revenue by Application
  2. 6.1.1 Global Human Papillomavirus Protein E7 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Papillomavirus Protein E7 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Papillomavirus Protein E7 Sales by Application
  6. 6.2.1 Global Human Papillomavirus Protein E7 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Papillomavirus Protein E7 Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Human Papillomavirus Protein E7 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Papillomavirus Protein E7 Price by Application
7 Company Profiles
  1. 7.1 VLPbio
  2. 7.1.1 VLPbio Company Information
  3. 7.1.2 VLPbio Business Overview
  4. 7.1.3 VLPbio Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 VLPbio Human Papillomavirus Protein E7 Product Portfolio
  6. 7.1.5 VLPbio Recent Developments
  7. 7.2 Transgene SA
  8. 7.2.1 Transgene SA Company Information
  9. 7.2.2 Transgene SA Business Overview
  10. 7.2.3 Transgene SA Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Transgene SA Human Papillomavirus Protein E7 Product Portfolio
  12. 7.2.5 Transgene SA Recent Developments
  13. 7.3 Touchlight Genetics Ltd
  14. 7.3.1 Touchlight Genetics Ltd Company Information
  15. 7.3.2 Touchlight Genetics Ltd Business Overview
  16. 7.3.3 Touchlight Genetics Ltd Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Touchlight Genetics Ltd Human Papillomavirus Protein E7 Product Portfolio
  18. 7.3.5 Touchlight Genetics Ltd Recent Developments
  19. 7.4 Selecta Biosciences Inc
  20. 7.4.1 Selecta Biosciences Inc Company Information
  21. 7.4.2 Selecta Biosciences Inc Business Overview
  22. 7.4.3 Selecta Biosciences Inc Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Selecta Biosciences Inc Human Papillomavirus Protein E7 Product Portfolio
  24. 7.4.5 Selecta Biosciences Inc Recent Developments
  25. 7.5 MedImmune LLC
  26. 7.5.1 MedImmune LLC Company Information
  27. 7.5.2 MedImmune LLC Business Overview
  28. 7.5.3 MedImmune LLC Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 MedImmune LLC Human Papillomavirus Protein E7 Product Portfolio
  30. 7.5.5 MedImmune LLC Recent Developments
  31. 7.6 Inovio Pharmaceuticals Inc
  32. 7.6.1 Inovio Pharmaceuticals Inc Company Information
  33. 7.6.2 Inovio Pharmaceuticals Inc Business Overview
  34. 7.6.3 Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Product Portfolio
  36. 7.6.5 Inovio Pharmaceuticals Inc Recent Developments
  37. 7.7 Immunovaccine Inc
  38. 7.7.1 Immunovaccine Inc Company Information
  39. 7.7.2 Immunovaccine Inc Business Overview
  40. 7.7.3 Immunovaccine Inc Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Immunovaccine Inc Human Papillomavirus Protein E7 Product Portfolio
  42. 7.7.5 Immunovaccine Inc Recent Developments
  43. 7.8 iBio Inc
  44. 7.8.1 iBio Inc Company Information
  45. 7.8.2 iBio Inc Business Overview
  46. 7.8.3 iBio Inc Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 iBio Inc Human Papillomavirus Protein E7 Product Portfolio
  48. 7.8.5 iBio Inc Recent Developments
  49. 7.9 Hookipa Biotech AG
  50. 7.9.1 Hookipa Biotech AG Company Information
  51. 7.9.2 Hookipa Biotech AG Business Overview
  52. 7.9.3 Hookipa Biotech AG Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hookipa Biotech AG Human Papillomavirus Protein E7 Product Portfolio
  54. 7.9.5 Hookipa Biotech AG Recent Developments
  55. 7.10 Genexine Inc
  56. 7.10.1 Genexine Inc Company Information
  57. 7.10.2 Genexine Inc Business Overview
  58. 7.10.3 Genexine Inc Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Genexine Inc Human Papillomavirus Protein E7 Product Portfolio
  60. 7.10.5 Genexine Inc Recent Developments
  61. 7.11 Formune SL
  62. 7.11.1 Formune SL Company Information
  63. 7.11.2 Formune SL Business Overview
  64. 7.11.3 Formune SL Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Formune SL Human Papillomavirus Protein E7 Product Portfolio
  66. 7.11.5 Formune SL Recent Developments
  67. 7.12 Etubics Corp
  68. 7.12.1 Etubics Corp Company Information
  69. 7.12.2 Etubics Corp Business Overview
  70. 7.12.3 Etubics Corp Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Etubics Corp Human Papillomavirus Protein E7 Product Portfolio
  72. 7.12.5 Etubics Corp Recent Developments
  73. 7.13 Cancer Research Technology Ltd
  74. 7.13.1 Cancer Research Technology Ltd Company Information
  75. 7.13.2 Cancer Research Technology Ltd Business Overview
  76. 7.13.3 Cancer Research Technology Ltd Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Cancer Research Technology Ltd Human Papillomavirus Protein E7 Product Portfolio
  78. 7.13.5 Cancer Research Technology Ltd Recent Developments
  79. 7.14 BioNTech AG
  80. 7.14.1 BioNTech AG Company Information
  81. 7.14.2 BioNTech AG Business Overview
  82. 7.14.3 BioNTech AG Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 BioNTech AG Human Papillomavirus Protein E7 Product Portfolio
  84. 7.14.5 BioNTech AG Recent Developments
  85. 7.15 Bioleaders Corp
  86. 7.15.1 Bioleaders Corp Company Information
  87. 7.15.2 Bioleaders Corp Business Overview
  88. 7.15.3 Bioleaders Corp Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Bioleaders Corp Human Papillomavirus Protein E7 Product Portfolio
  90. 7.15.5 Bioleaders Corp Recent Developments
  91. 7.16 Advaxis Inc
  92. 7.16.1 Advaxis Inc Company Information
  93. 7.16.2 Advaxis Inc Business Overview
  94. 7.16.3 Advaxis Inc Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Advaxis Inc Human Papillomavirus Protein E7 Product Portfolio
  96. 7.16.5 Advaxis Inc Recent Developments
  97. 7.17 Abion Inc
  98. 7.17.1 Abion Inc Company Information
  99. 7.17.2 Abion Inc Business Overview
  100. 7.17.3 Abion Inc Human Papillomavirus Protein E7 Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Abion Inc Human Papillomavirus Protein E7 Product Portfolio
  102. 7.17.5 Abion Inc Recent Developments
8 North America
  1. 8.1 North America Human Papillomavirus Protein E7 Market Size by Type
  2. 8.1.1 North America Human Papillomavirus Protein E7 Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Papillomavirus Protein E7 Sales by Type (2021-2032)
  4. 8.1.3 North America Human Papillomavirus Protein E7 Price by Type (2021-2032)
  5. 8.2 North America Human Papillomavirus Protein E7 Market Size by Application
  6. 8.2.1 North America Human Papillomavirus Protein E7 Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Papillomavirus Protein E7 Sales by Application (2021-2032)
  8. 8.2.3 North America Human Papillomavirus Protein E7 Price by Application (2021-2032)
  9. 8.3 North America Human Papillomavirus Protein E7 Market Size by Country
  10. 8.3.1 North America Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Papillomavirus Protein E7 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Papillomavirus Protein E7 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Human Papillomavirus Protein E7 Market Size by Type
  2. 9.1.1 Europe Human Papillomavirus Protein E7 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Papillomavirus Protein E7 Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Papillomavirus Protein E7 Price by Type (2021-2032)
  5. 9.2 Europe Human Papillomavirus Protein E7 Market Size by Application
  6. 9.2.1 Europe Human Papillomavirus Protein E7 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Papillomavirus Protein E7 Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Papillomavirus Protein E7 Price by Application (2021-2032)
  9. 9.3 Europe Human Papillomavirus Protein E7 Market Size by Country
  10. 9.3.1 Europe Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Papillomavirus Protein E7 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Papillomavirus Protein E7 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Human Papillomavirus Protein E7 Market Size by Type
  2. 10.1.1 China Human Papillomavirus Protein E7 Revenue by Type (2021-2032)
  3. 10.1.2 China Human Papillomavirus Protein E7 Sales by Type (2021-2032)
  4. 10.1.3 China Human Papillomavirus Protein E7 Price by Type (2021-2032)
  5. 10.2 China Human Papillomavirus Protein E7 Market Size by Application
  6. 10.2.1 China Human Papillomavirus Protein E7 Revenue by Application (2021-2032)
  7. 10.2.2 China Human Papillomavirus Protein E7 Sales by Application (2021-2032)
  8. 10.2.3 China Human Papillomavirus Protein E7 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Papillomavirus Protein E7 Market Size by Type
  2. 11.1.1 Asia Human Papillomavirus Protein E7 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Papillomavirus Protein E7 Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Papillomavirus Protein E7 Price by Type (2021-2032)
  5. 11.2 Asia Human Papillomavirus Protein E7 Market Size by Application
  6. 11.2.1 Asia Human Papillomavirus Protein E7 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Papillomavirus Protein E7 Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Papillomavirus Protein E7 Price by Application (2021-2032)
  9. 11.3 Asia Human Papillomavirus Protein E7 Market Size by Country
  10. 11.3.1 Asia Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Papillomavirus Protein E7 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Papillomavirus Protein E7 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Papillomavirus Protein E7 Market Size by Type
  2. 12.1.1 SAMEA Human Papillomavirus Protein E7 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Papillomavirus Protein E7 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Papillomavirus Protein E7 Price by Type (2021-2032)
  5. 12.2 SAMEA Human Papillomavirus Protein E7 Market Size by Application
  6. 12.2.1 SAMEA Human Papillomavirus Protein E7 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Papillomavirus Protein E7 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Papillomavirus Protein E7 Price by Application (2021-2032)
  9. 12.3 SAMEA Human Papillomavirus Protein E7 Market Size by Country
  10. 12.3.1 SAMEA Human Papillomavirus Protein E7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Papillomavirus Protein E7 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Papillomavirus Protein E7 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Papillomavirus Protein E7 Value Chain Analysis
  2. 13.1.1 Human Papillomavirus Protein E7 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Papillomavirus Protein E7 Production Mode & Process
  6. 13.2 Human Papillomavirus Protein E7 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Papillomavirus Protein E7 Distributors
  9. 13.2.3 Human Papillomavirus Protein E7 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst